| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,407 | 12,051 | 12,844 | 13,534 | | Cost of Revenue | 2,561 | 3,237 | 4,017 | 5,257 | | | Gross Profit |
-
| 8,814 | 8,827 | 8,277 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,462 | 4,514 | 4,655 | (90,069) | | Non Recurring | (5,125) | 4,100 | 1,025 | 94,346 | | Others | 1,000 | 400 | 150 | 4,614 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (200) | 2,997 | (614) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,491) | (200) | 2,997 | (614) | | Interest Expense | 1,187 | 1,169 | 1,351 | 1,355 | | Income Before Tax | (2,678) | (1,369) | 1,646 | (1,969) | | Income Tax Expense | (285) | 1,066 | 577 | (5,467) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,393) | (2,435) | 1,069 | 3,498 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,393) | (2,435) | 1,069 | 3,498 | | Preferred Stock And Other Adjustments | (1,200) | (1,200) | (1,200) |
-
| | | Net Income Applicable To Common Shares | ($3,593) | ($3,635) | ($131) | $3,498 |
|
0.01% Nasdaq 0.00%
Income Statement
